 | Up a level |
Cosgarea, I, Zimmer, L., Weide, B., Gutzmer, R., Heinzerling, L., Weishaupt, C., Pfoehler, C., Gesierich, A., Herbst, R., Kaehler, K., Schlaak, M., Loquai, C., Utikal, J., Kaatz, M., Berking, C., Kreuter, A., Ulrich, J., Mohr, P., Dippel, E., Livingstone, E., Weichenthal, M., Schadendorf, D. and Ugurel, S. (2017). Interleukin-2 and Checkpoint Inhibition as a successful Therapy Sequence for metastatic Melanoma: Case Report and retrospective Analysis in 52 Patients. J. Dtsch. Dermatol. Ges., 15. S. 16 - 18. HOBOKEN: WILEY. ISSN 1610-0387
Gaiser, M. R., Orouji, A., Hirsch, D., Bach, M., Kind, P., Helbig, D., Quaas, A., Utikal, J., Marx, A. and Gaiser, T. (2018). MYC Gene Amplification is a rare Event in Atypical Fibroxanthoma and Pleomorphic dermal Sarcoma. J. Dtsch. Dermatol. Ges., 16. S. 13 - 14. HOBOKEN: WILEY. ISSN 1610-0387
Hassel, J., Forschner, A., Bluhm, L., Heinzerling, L., Zimmer, L., Utikal, J., Kaehler, K., Schlaak, M., Loquai, C., Gutzmer, R., Kieker, F., Berking, C., Bender, A., Schneider, L., Enk, A., Garbe, C., Weichenthal, M., Schadendorf, D., Hauschild, A. and Mohr, P. (2016). Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP). J. Dtsch. Dermatol. Ges., 14. S. 9 - 10. HOBOKEN: WILEY-BLACKWELL. ISSN 1610-0387
Kunz, M., Dannemann, M., Dose, G., Kelso, J., Hoffmann, S., Landsberg, J., Tueting, T., Zigrino, P., Mauch, C., Kottek, T., Utikal, J., Schulze, H., Ziemer, M., Simon, J., Bosserhoff, A. and Schartl, M. (2017). RNA-Seq analysis of benign melanocytic nevi and primary melanomas. Exp. Dermatol., 26 (3). S. E86 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Leufke, C., Leykauf, J., Krunic, D., Jauch, A., Holtgreve-Grez, H., Boehm-Steuer, B., Broecker, E-B, Mauch, C., Utikal, J., Hartschuh, W., Purdie, K. J. and Boukamp, P. (2014). The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas. Oncogene, 33 (27). S. 3506 - 3519. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5594